New Beauty and The New York Times recently posted articles on skin care after weight loss from GLP-1 agonists
When lifestyle changes are not enough, many people turn to medical support
Patients should inform their procedural and anesthesia teams if they take GLP-1 or dual incretin therapy, including Ozempic, Wegovy, Rybelsus, Trulicity, Victoza, Saxenda, Mounjaro, or Zepbound
Moreover, a large number of clinical trials and early regulatory approvals accelerate the introduction of new formulations
Commercially available GLP-1 patches lack clinical evidence for safety and efficacy and might lead to adverse reactions
Hydration plays a crucial role in maintaining healthy bowel movements